JPRN-jRCTs051210192已完成未知
Efficacy and Safety study of the therapeutic approach using ketamine in refractory depression.
Murai Toshiya0 个研究点目标入组 10 人开始时间: 2022年3月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Men or women over 18 years (inclusive).
- •2) Having provided voluntary written consent for participation in this study. If younger than 20 years, Legal representative also has to aggree with the consent.
- •3) Meet Diagnostic and Statistical Manual of Mental Disorders-5th Edition (DSM-5) diagnostic criteria for major depressive disorder (MDD), based upon the Mini-International Neuropsychiatric Interview, M.I.N.I. The length of the current depressive episode must be longer than or equal to (>=)4 weeks.
- •4) The MADRS score is higher than or equal to 17, and BDI-II score is higher than or equal to 14.
- •5) Have had an inadequate response to at least 1 antidepressant, administered at an adequate dose and duration in the current episode of depression, or intolerant to more than one antidepressant.
排除标准
- •1) Patient has complications such as serious hepatic disorder, renal disorder, heart disease,
- •lung disease, hematological disease, and metabolic disease.
- •2) Non-responder to esketamine or ketamine in the depressive episode.
- •3) Patient has had complications such as neurodevelopmental disorders, schizophrenic disorders, PTSD, Disruptive, impulse-control, and conduct disorders.
- •4) Patient has complictions such as obsessive-complusivity disorders, anorexia nervosa, bulimia nervosa,
- •binge eating disorder, neurocognitive disorders, disruptive mood dysregulation disorder.
- •5) Patient has complication such as epilepsy (including medical history), sleep apnea syndrome, COPD.
- •6) Patient experienced gastric bypass surgery, gastric sleeve or lap band surgery, or treatment inhibiting gastrointestinal transit.
- •7) Corrected QT interval >450 msec on an electrocardiogram.
- •8) Patient with hypertension, systolic and diastolic blood pressures are >140mmHg and >90mmHg, respectively. For patients older than or equal to 65 years, systolic blood pressure is >150mmHg.
- •9) Significant observation in the Interview, clinical test or 12-lead electrocardiogram.
- •10) Patient with sucidal tendency and ideation judged with C-SSRS (yes in Q4, Q5 or questions about actual sucidal behaviors except for the item about non-intentional self-injuring behavior)
- •11) Patient violating the rules of adjunctive medications.
- •12) Patient has medical history of substance use disorders.
- •13) Positive in a urine drug screen (except for the case positive because of antidepressant therapy)
- •14) Pregnant or attempting to be pregnant during the study, and lactating.
- •15) Difficult to complete the study, having the potential to have disadvantages, difficult to ensure the safety, inappropriate to evaluate the safety and efficacy of the medicines used in this study, or inappropriate judged by principal investigator or subinvestigators.
- •16)Patients with a history of seizures or hypersensitivity to the components of KETALAR, and patients with cerebrovascular disorders, intracranial hypertension and severe cardiac decompensation.
研究者
相似试验
进行中（未招募）
不适用
Study on the effectiveness and safety of the treatment of hyponatremia due to inappropriate secretion of antidiuretic hormone (SIADH) with Tolvaptan vs fluid restriction in patients affected by pituitary disorders.EUCTR2012-004071-39-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO
已完成
不适用
Study on the safety and efficacy of the treatment of polidocanol injection for vascular lesions in the small bowel.Vascular lesions in the small bowelJPRN-UMIN000009712niversity of Tokyo20
已完成
2 期
A study on siddha medicine kumaara veeriya kaantha chenduram for anaemiaCTRI/2019/04/018795Ayothidoss Pandithar hospital30
尚未招募
2 期
Evaluation of safety and therapeutic efficacy of siddha drug KANDAAMALAGA ILAKAM in the treatment of Iron deficiency anaemia.CTRI/2018/05/014111Ayothidoss Pandithar Hospital
进行中（未招募）
1 期
Evaluation of the safety and efficacy of the treatment of chronic wounds in diabetic foot syndrome with the use of autologous stem cells isolated from adipose tissue - within the project: Therapeutic potential of adipose-derived stem cells, proven in clinical trials and examined in vitro - rationale for banking of well characterized cells”MedDRA version: 20.0 Level: LLT Classification code 10012664 Term: Diabetic foot ulcer System Organ Class: 100000004858Diabetic foot ulcerEUCTR2016-004109-15-PLMedical University of Warsaw50